During this unique time our nation is experiencing, Myriad is dedicated to finding solutions to ensure that patient care is not interrupted. Dr. Thomas Slavin, Senior Vice President of Medical Affairs for Myriad Oncology, provides more insight into what Myriad is offering to streamline the genetic testing process for providers. Our lifetime commitment to patients does not – and will not – change during this challenging time. #workingtogether #wearemyriad

Illuminating the path to better health through genetic insights

Our tests and screens reveal information to guide patients and providers to better health and well-being. Whether you’re searching for answers related to cancer risk, cancer treatment, prenatal care or mental health, Myriad screens and tests can help.